Antimicrobial susceptibility of Bacillus anthracis in an endemic area

被引:21
作者
Bakici, MZ
Elaldi, N [1 ]
Bakir, M
Dökmetas, I
Erandaç, M
Turan, M
机构
[1] Cumhuriyet Univ, Fac Med, Dept Clin Microbiol, Klin Bakteriyol & Ifeks, TR-58140 Sivas, Turkey
[2] Cumhuriyet Univ, Fac Med, Dept Clin Bacteriol & Infect Dis, TR-58140 Sivas, Turkey
[3] Cumhuriyet Univ, Fac Med, Dept Gen Surg, TR-58140 Sivas, Turkey
关键词
D O I
10.1080/00365540210147679
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We aimed to test the antimicrobial susceptibility of 28 Bacillus anthracis strains isolated from cutaneous anthrax cases to various antimicrobial agents using the Sceptor automatic system in an anthrax endemic area. All strains tested were susceptible to penicillin (MIC less than or equal to 0.03 mug/ml). Piperacillin-tazobactam and carbapenems showed good activity towards all strains. Trimethoprim-sulfamethoxazole and cefepime had no activity. Strains were also tested with other antimicrobials.
引用
收藏
页码:564 / 566
页数:3
相关论文
共 16 条
[1]   CUTANEOUS ANTHRAX DUE TO PENICILLIN-RESISTANT BACILLUS-ANTHRACIS TRANSMITTED BY AN INSECT BITE [J].
BRADARIC, N ;
PUNDAPOLIC, V .
LANCET, 1992, 340 (8814) :306-307
[2]   In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones [J].
Brook, I ;
Elliott, TB ;
Pryor, HI ;
Sautter, TE ;
Gnade, BT ;
Thakar, JH ;
Knudson, GB .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (06) :559-562
[3]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P909
[4]   In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne [J].
Choe, CH ;
Bouhaouala, SS ;
Brook, I ;
Elliott, TB ;
Knudson, GB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1766-1766
[5]   ANTIMICROBIAL SUSCEPTIBILITY OF BACILLUS-ANTHRACIS [J].
DOGANAY, M ;
AYDIN, N .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, 23 (03) :333-335
[6]   PRIMARY THROAT ANTHRAX - A REPORT OF 6 CASES [J].
DOGANAY, M ;
ALMAC, A ;
HANAGASI, R .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1986, 18 (05) :415-419
[7]  
DOGANAY M, 1990, SALISBURY MED B S, V68, pS13
[8]   ANTHRAX - A REPORT OF 117 CASES [J].
GOLD, H .
ARCHIVES OF INTERNAL MEDICINE, 1955, 96 (03) :387-396
[9]   Pulmonary manifestations of bioterrorism [J].
Heddurshetti R. ;
Pumpradit W. ;
Lutwick L.I. .
Current Infectious Disease Reports, 2001, 3 (3) :249-257
[10]   Anthrax as a biological weapon - Medical and public health management [J].
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Friedlander, AM ;
Hauer, J ;
McDade, J ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (18) :1735-1745